Discontinued — last reported Q2 '25
Non-Current Assets
Other Non-Current Assets
Biogen Other Non-Current Assets increased by 3.6% to $777.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.1%, from $559.10M to $777.50M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows a downward trend with a -23.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2021
Last reportedQ2 2025
How to read this metric
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
Detailed definition
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Peer comparison
Often contains strategic minority investments in technology partners or long-term tax-related items.
Metric ID:
other_non_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.53B | $2.02B | $1.94B | $1.77B | $1.50B | $1.61B | $1.53B | $1.38B | $1.10B | $754.60M | $745.00M | $697.60M | $681.50M | $631.40M | $560.50M | $559.10M | $637.70M | $729.70M | $750.60M | $777.50M |
| QoQ Change | — | -20.2% | -3.9% | -8.9% | -15.1% | +7.4% | -5.2% | -9.7% | -20.0% | -31.7% | -1.3% | -6.4% | -2.3% | -7.4% | -11.2% | -0.2% | +14.1% | +14.4% | +2.9% | +3.6% |
| YoY Change | — | — | — | — | -40.6% | -20.1% | -21.2% | -21.9% | -26.4% | -53.2% | -51.3% | -49.5% | -38.3% | -16.3% | -24.8% | -19.9% | -6.4% | +15.6% | +33.9% | +39.1% |
Range$559.10M – $2.53B
CAGR-22.0%
Avg YoY Growth-18.8%
Median YoY Growth-21.5%
Current Streak4 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Biogen's other non-current assets?
- Biogen (BIIB) reported other non-current assets of $777.50M in Q1 2026.
- How has Biogen's other non-current assets changed year-over-year?
- Biogen's other non-current assets increased by 39.1% year-over-year, from $559.10M to $777.50M.
- What is the long-term trend for Biogen's other non-current assets?
- Over 5 years (2020 to 2025), Biogen's other non-current assets has grown at a -23.7% compound annual growth rate (CAGR), from $2.90B to $750.60M.
- What does other non-current assets mean?
- Miscellaneous long-term investments and assets that the company plans to hold for more than a year.